Related Experiment Videos

Insight into hepatotoxicity: The troglitazone experience

Hepatology (Baltimore, Md.)

|January 20, 2005

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Quantitative Systems Toxicology Model Predicts Obeticholic Acid-Associated Liver Injury in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Clinical pharmacology and therapeutics·2026

A Phase 1 Dose-Escalation, Food Effect, and Drug-Drug Interaction Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the MALT1 Inhibitor, SGR-1505, in Healthy Volunteers.

Clinical pharmacology in drug development·2026

Quantitative Systems Toxicology Modeling with DILIsym to Support Phase 3 Dose Selection for Fezolinetant.

Clinical pharmacology and therapeutics·2026

Blood toxicogenomics reveals potential biomarkers for management of idiosyncratic drug-induced liver injury.

Frontiers in genetics·2025

Assessment of liver injury potential of investigational medicines in drug development.

Hepatology (Baltimore, Md.)·2025

Tolvaptan safety in autosomal-dominant polycystic kidney disease; a focus on idiosyncratic drug-induced liver injury liabilities.

Toxicological sciences : an official journal of the Society of Toxicology·2024

See all related articles